News for 'India's Food and Drug Administration'

Why India's pharma cos prefer Gujarat over tax havens

Why India's pharma cos prefer Gujarat over tax havens

Rediff.com23 Sep 2017

Gujarat has around 3,000 licensees for allopathic drug manufacturing, apart from around seven homeopathic licensees, 500 ayuvedic and 600-700 cosmetics licensees

Dr Reddy's sued in US court by S Korean pharma co

Dr Reddy's sued in US court by S Korean pharma co

Rediff.com27 Jan 2017

Suit alleges fraud by hiding significant deficiencies in CGMP regulations enforced by US health regulator.

Hydroxychloroquine doesn't help treat COVID-19: Report

Hydroxychloroquine doesn't help treat COVID-19: Report

Rediff.com22 Apr 2020

Trump has been aggressively promoting the use of hydroxychloroquine in the treatment of COVID-19 patients.

Indian pharma exports report double-digit growth after 3 yrs

Indian pharma exports report double-digit growth after 3 yrs

Rediff.com3 May 2019

The only category of pharmaceuticals that showed a negative growth in exports this time was herbal products, exports of which stood at $299 million as compared to $ 312 million in the previous year.

Covid: First Indian to get Trump cocktail discharged from hospital

Covid: First Indian to get Trump cocktail discharged from hospital

Rediff.com26 May 2021

Mohabbat Singh was administered a cocktail of Casirivimab and Imdevimab at the Medanta Hospital as part of the "single dose infusion-based treatment" on Tuesday and then kept under observation.

Markets end flat on caution ahead of Fed, RBI meet

Markets end flat on caution ahead of Fed, RBI meet

Rediff.com16 Sep 2013

The broader markets ended negatively with mid-caps and small-caps shedding 0.5 per cent on the BSE.

Lapses by some pharma cos overshadowed good things: FDA chief

Lapses by some pharma cos overshadowed good things: FDA chief

Rediff.com12 Feb 2014

On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.

As Maggi goes off menu, Nestle gears up for damage control

As Maggi goes off menu, Nestle gears up for damage control

Rediff.com28 May 2015

The central government has said it will look into the matter.

Maggi, banned. And oil, eggs, vegetables, pulses?

Maggi, banned. And oil, eggs, vegetables, pulses?

Rediff.com8 Jun 2015

We are surrounded by food that is contaminated, adulterated and does not meet Indian safety and packaging standards, says Abheet Singh Sethi/IndiaSpend.com.

US FDA tightens regulatory noose on Indian drug firms

US FDA tightens regulatory noose on Indian drug firms

Rediff.com17 Sep 2013

Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter

'Believe me, nobody can do reassurance better than Mr Modi'

'Believe me, nobody can do reassurance better than Mr Modi'

Rediff.com1 Oct 2023

'You ain't seen anything yet,' EAM Jaishankar says about the India-US relationship.

Dr Reddy's sued for patent 'infringement'

Dr Reddy's sued for patent 'infringement'

Rediff.com19 Jun 2013

The US Drug maker requested the court to pass an order to restrain DRL from commercially manufacturing, using, offering for sale, selling, marketing, distributing, or importing DRL's generic paricalcitol injectable products prior to the expiration of said patents.

Ranbaxy to pay $39.75 mn for litigation settlement with Texas

Ranbaxy to pay $39.75 mn for litigation settlement with Texas

Rediff.com16 Oct 2014

Last year, Ranbaxy had paid around $4,20,000 to the US state of Idaho as part of a $500-million settlement that the drug firm had signed with US authorities.

Maggi ban: Regulator overreach, says Nestle counsel

Maggi ban: Regulator overreach, says Nestle counsel

Rediff.com21 Jul 2015

Nestle India has been arguing that ban order was arbitrary.

'Ranbaxy got USFDA nod with no data or fraudulent data'

'Ranbaxy got USFDA nod with no data or fraudulent data'

Rediff.com7 Nov 2013

In May this year, Ranbaxy had pleaded guilty to 'felony charges' for violating manufacturing norms and agreed to pay $500 million penalty to US authorities.

Markets end on a weak note dragged by pharma shares

Markets end on a weak note dragged by pharma shares

Rediff.com29 Mar 2016

Top 5 losers include Lupin, Cipla, Sun Pharma, Dr Reddy's Lab and GAIL down 1.6%-11%.

Pursuing foreign companies since mid-2020 for possible vaccine imports: Govt

Pursuing foreign companies since mid-2020 for possible vaccine imports: Govt

Rediff.com27 May 2021

Facing accusations of delay in placing orders for vaccines, the government on Thursday defended its vaccine procurement policy saying it has been pursuing Pfizer, J&J and Moderna since mid-2020 for the earliest possible imports, and has even waived local trials for well-established foreign vaccine makers.

Safety concerns over Maggi noodles back to haunt Nestle

Safety concerns over Maggi noodles back to haunt Nestle

Rediff.com30 Nov 2017

This time food regulators found excess presence of ash content in Maggi

Bengaluru start-up prints 3D tissue that functions like human liver

Bengaluru start-up prints 3D tissue that functions like human liver

Rediff.com23 Dec 2015

In India, thousands of lives are lost every year because of unavailability of organs

Mess led Nestl to rope in crisis managers

Mess led Nestl to rope in crisis managers

Rediff.com14 Aug 2015

The meetings were a sign of crisis management.

Ranbaxy brands to stay alive

Ranbaxy brands to stay alive

Rediff.com8 Aug 2014

Sun Pharma to retain these in most markets; US could be the exception, where the Ranbaxy name has taken a hit.

No plans to reduce workforce: Ranbaxy

No plans to reduce workforce: Ranbaxy

Rediff.com2 Oct 2013

The company has been reported to be retrenching staff.

Maggie on the boil! Madhuri, Amitabh feel the heat; case against Nestle

Maggie on the boil! Madhuri, Amitabh feel the heat; case against Nestle

Rediff.com30 May 2015

A case was lodged on Saturday against Nestle India in a local court here over safety standards of its Maggi product, while actors Amitabh Bachhan, Madhuri Dixit and Preity Zinta have also been separately dragged to the court for promoting the 'two-minute' noodles brand.

Nestle to face more action over Maggi?

Nestle to face more action over Maggi?

Rediff.com21 May 2015

Fast Moving Consumer Goods major Nestle may face more action by the Uttar Pradesh Food Safety and Drug Administration, which is testing more batches of Maggi after ordering recall of a batch of about 2 lakh packs of the instant noodles due to higher than permitted levels of lead and a food additive.

China rolls out first one-jab COVID-19 vaccine: Report

China rolls out first one-jab COVID-19 vaccine: Report

Rediff.com28 Feb 2021

China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the United States drug regulator on Sunday.

V G Somani: The head of DCGI known as man of actions, not of words

V G Somani: The head of DCGI known as man of actions, not of words

Rediff.com18 Jan 2021

'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'

US FDA likely to inspect new Visakhapatnam arm of Divi's Labs in Jan

US FDA likely to inspect new Visakhapatnam arm of Divi's Labs in Jan

Rediff.com31 Dec 2013

The move assumes significance because a go-ahead from the US Food and Drug Administration for the new unit in Visakhapatnam is likely to give a huge boost to the company's revenues in upcoming quarters.

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Rediff.com21 Oct 2014

On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.

'Ham-handed' action against Snapdeal to hurt business: Pilot

'Ham-handed' action against Snapdeal to hurt business: Pilot

Rediff.com3 May 2015

He said action was akin to holding highway builders responsible for lane violations

US gives clean chit to Maggi: Do you want it back?

US gives clean chit to Maggi: Do you want it back?

Rediff.com12 Aug 2015

Nestl India is preparing a blueprint for a possible relaunch.

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

Rediff.com10 Mar 2014

The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.

Cadila believes it has silver bullet to fight COVID-19

Cadila believes it has silver bullet to fight COVID-19

Rediff.com21 Apr 2020

Can Interferon alfa-2b treat COVID-19 effectively?

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Rediff.com17 Sep 2021

Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.

Why govt has failed to check the spread of coronavirus in India

Why govt has failed to check the spread of coronavirus in India

Rediff.com23 Mar 2020

An overarching law governing public healthcare is a glaring gap in India's fight against the COVID-19 pandemic. In India it is left to individuals to quarantine themselves voluntarily. Moreover, the 123-year old The Epidemic Diseases Act, 1897, governs healthcare emergencies in India.

Indian drugmakers to pay higher facility fees on US hike

Indian drugmakers to pay higher facility fees on US hike

Rediff.com3 Aug 2014

The US laws authorise the drug and health watchdog to assess and collect user fees for certain applications and supplements for human generic drug products

Centre may not get costly Pfizer vaccine

Centre may not get costly Pfizer vaccine

Rediff.com22 Dec 2020

At $37 per dose, the Pfizer vaccine is much more expensive compared to $3 per dose for the Covishield.

COVAX urges equal recognition of WHO approved vaccines

COVAX urges equal recognition of WHO approved vaccines

Rediff.com2 Jul 2021

Calling for 'equal recognition of vaccines', COVAX on Thursday urged all governments to recognise as 'fully vaccinated' those people who have received COVID-19 vaccines deemed safe by World Health Organisation, saying any move that restricts travel of people based on the vaccines they have received is 'counter-effective, both in spirit and outcome'.

Sun Pharma to delist Ranbaxy on completion of $4-bn merger

Sun Pharma to delist Ranbaxy on completion of $4-bn merger

Rediff.com25 Mar 2015

The merger has fortified Sun Pharma's position.

Did Nestle India have the option to stop total Maggi recall?

Did Nestle India have the option to stop total Maggi recall?

Rediff.com10 Aug 2015

Nestle refused to regret the mistake in a public statement.

India Inc lines up as demand for rapid testing for coronavirus grows

India Inc lines up as demand for rapid testing for coronavirus grows

Rediff.com3 Apr 2020

The test used now, called PCR (or polymerace chain reaction), uses a nasal or throat swab sample and identifies the virus. These tests take at least five hours to give results. The rapid test, on the other hand, uses a blood sample and gives results based on detecting the presence of certain antibodies that react to the coronavirus protein.